|
[PMID]: | 28167741 |
[Au] Autor: | De Min A; Matera C; Bock A; Holze J; Kloeckner J; Muth M; Traenkle C; De Amici M; Kenakin T; Holzgrabe U; Dallanoce C; Kostenis E; Mohr K; Schrage R |
[Ad] Endereço: | Pharmacology and Toxicology Section, Institute of Pharmacy (A.D.M., J.H., C.T., K.M., R.S.), Research Training Group 1873 (A.D.M., E.K., K.M.), and Molecular-, Cellular-, and Pharmacobiology Section, Institute of Pharmaceutical Biology (E.K.), University of Bonn, Bonn, Germany; Dipartimento di Scien |
[Ti] Título: | A New Molecular Mechanism To Engineer Protean Agonism at a G Protein-Coupled Receptor. |
[So] Source: | Mol Pharmacol;91(4):348-356, 2017 Apr. | [Is] ISSN: | 1521-0111 |
[Cp] País de publicação: | United States |
[La] Idioma: | eng |
[Ab] Resumo: | Protean agonists are of great pharmacological interest as their behavior may change in magnitude and direction depending on the constitutive activity of a receptor. Yet, this intriguing phenomenon has been poorly described and understood, due to the lack of stable experimental systems and design strategies. In this study, we overcome both limitations: First, we demonstrate that modulation of the ionic strength in a defined experimental set-up allows for analysis of G protein-coupled receptor activation in the absence and presence of a specific amount of spontaneous receptor activity using the muscarinic M acetylcholine receptor as a model. Second, we employ this assay system to show that a dualsteric design principle, that is, molecular probes, carrying two pharmacophores to simultaneously adopt orthosteric and allosteric topography within a G protein-coupled receptor, may represent a novel approach to achieve protean agonism. We pinpoint three molecular requirements within dualsteric compounds that elicit protean agonism at the muscarinic M acetylcholine receptor. Using radioligand-binding and functional assays, we posit that dynamic ligand binding may be the mechanism underlying protean agonism of dualsteric ligands. Our findings provide both new mechanistic insights into the still enigmatic phenomenon of protean agonism and a rationale for the design of such compounds for a G protein-coupled receptor. |
[Mh] Termos MeSH primário: |
Engenharia de Proteínas Receptores Acoplados a Proteínas-G/agonistas
|
[Mh] Termos MeSH secundário: |
Regulação Alostérica Animais Células CHO Cricetinae Cricetulus Seres Humanos Ligantes Ligação Proteica Receptor Muscarínico M2/metabolismo Receptores Acoplados a Proteínas-G/metabolismo Trometamina
|
[Pt] Tipo de publicação: | JOURNAL ARTICLE |
[Nm] Nome de substância:
| 0 (Ligands); 0 (Receptor, Muscarinic M2); 0 (Receptors, G-Protein-Coupled); 023C2WHX2V (Tromethamine) |
[Em] Mês de entrada: | 1705 |
[Cu] Atualização por classe: | 170509 |
[Lr] Data última revisão:
| 170509 |
[Sb] Subgrupo de revista: | IM |
[Da] Data de entrada para processamento: | 170208 |
[St] Status: | MEDLINE |
[do] DOI: | 10.1124/mol.116.107276 |
|
|
|